Ipilimumab
ACCRU-GI-2017
Phase 2 mab terminated
Quick answer
Ipilimumab for BCLC Stage B Hepatocellular Carcinoma is a Phase 2 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- BCLC Stage B Hepatocellular Carcinoma
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated